Paris court rejects drug company’s case against journalBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d1498 (Published 07 March 2011) Cite this as: BMJ 2011;342:d1498
- Paul Benkimoun
A French drug company that sued a journal for criticising one of its drugs has lost its case in a Paris court.
Astellas Pharma had sued the French monthly Prescrire, claiming that the journal had unfairly criticised its product Protopic (tacrolimus ointment). In a ruling published on 2 March the Paris Civil Court rejected the company’s lawsuit.
Prescrire is a monthly journal published by the Association Mieux Prescrire, which describes itself as a non-profit organisation committed to …
Log in using your username and password
Log in through your institution
Sign up for a free trial